Skip to content

Efficacy of Distant Healing in Glioblastoma Treatment

Efficacy of Distant Healing in Glioblastoma Treatment

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00029783
Enrollment
150
Registered
2002-01-24
Start date
2000-09-30
Completion date
2005-06-30
Last updated
2006-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioblastoma

Keywords

Glioblastoma, Brain tumor, Distant healing, Distance healing

Brief summary

This study will assess whether distant healing effects survival time and loss of function for glioblastoma patients.

Detailed description

Prayer, energy healing, and spiritual healing are widely used for all degrees of illness. Eisenberg (1998) reported that more that 26% of his survey sample used energy healing within the last year. Most of these practitioners believe that their inner intentions result in the benefits, either through the agency of love, energy, or a Higher Power (Benor 1992). However, the conventional community attributes benefits from these interventions to the patient's hope, expectation, or experience of support from a practitioner (Benson 1996). The proposed study is a double-blind randomized controlled clinical trial of distant healing intentionality. Distant Healing (DH) is defined as a mental intention on behalf of one person, to benefit another at a distance. This study will assess whether DH effects survival time and loss of function for glioblastoma patients under conditions where hope and expectation are controlled. The study will include approximately 150 patients who have rapidly progressing glioblastoma and are beginning radiotherapy. Patients will be photographed and assessed for quality of life, psychological status, and physical symptoms as well as health habits and attitude toward DH. After stratification by age and functional status (Karnofsky score), patients will be randomly assigned to either standard treatment with or without DH. Healers from diverse schools and backgrounds from communities across the United States will be assigned to patients by rotation, so that each patient in the DH group will be treated for two weeks by 10 different healers over the 20 week intervention. Experienced healers will have photographs of subjects and send mental intention for health and well being to subjects for one hour daily, three times per week. The healing intervention will be performed at a distance, and patients and healers will never meet, nor will patients know their group assignment. The study findings will provide the basis for developing a larger study, definitive trial.

Interventions

PROCEDUREDistant Healing

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

Inclusion: * Histologically confirmed diagnosis of glioblastoma based on open resection. * Patient is within five weeks of diagnosis confirmed by pathology report. Exclusion: * Non-English speaking. * Inability or unwillingness to fill out questionnaires. * History of other cancers within the last 2 years (except superficial basal cell, squamous cell carcinoma of the skin), or other concurrent life-threatening conditions.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026